Microenvironment-Driven Reprogramming in Colorectal Cancer Liver Metastasis: Metabolic, Phenotypic, and Immune Adaptation
International Journal of Molecular Sciences · 11.07.2026 · 27 (14) · 6206
DOI: 10.3390/ijms27146206 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.07.2026. Verfasst von Xiaoli Mu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Health Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Tumor Microenvironment. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Provincial Department of Science and Technology.
Abstract (Originalsprache)
Liver metastasis is a major cause of mortality in patients with metastatic colorectal cancer and reflects the selective pressures imposed by the hepatic niche. This review summarizes how the liver microenvironment may reshape disseminated colorectal cancer cells through three interconnected programs: metabolic reprogramming, phenotypic plasticity, and immune evasion. Metabolically, metastatic cells adapt to the glucose-poor and lipid-rich hepatic milieu by switching between glycolysis and oxidative phosphorylation, activating gluconeogenesis, increasing glutamine dependence, and remodeling lipid utilization. Phenotypically, stromal cues such as TGF-β and HGF may promote epithelial–mesenchymal plasticity, thereby supporting invasion, survival, and metastatic outgrowth. Immunologically, the hepatic niche facilitates immune escape through PD-L1 upregulation and the recruitment or polarization of suppressive myeloid and regulatory T-cell populations. We further discuss therapeutic opportunities arising from these vulnerabilities, including inhibition of metabolic dependencies, blockade of TGF-β/FAK-driven plasticity, and combination immunotherapy targeting the PD-1/PD-L1 axis together with the liver immune microenvironment. Finally, we highlight the need for biomarker-guided patient stratification, more faithful preclinical models, and rational combination strategies to overcome adaptive resistance and improve outcomes in colorectal liver metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Pain Management, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Oncology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Wenjun Meng
Förderung
- Sichuan Provincial Department of Science and Technology
Zitieren
APA
Mu, X., Meng, W., & Zheng, L. (2026). Microenvironment-Driven Reprogramming in Colorectal Cancer Liver Metastasis: Metabolic, Phenotypic, and Immune Adaptation. International Journal of Molecular Sciences, 27(14), 6206. https://doi.org/10.3390/ijms27146206
Vancouver
Mu X, Meng W, Zheng L. Microenvironment-Driven Reprogramming in Colorectal Cancer Liver Metastasis: Metabolic, Phenotypic, and Immune Adaptation. International Journal of Molecular Sciences. 2026;27(14):6206. doi:10.3390/ijms27146206
BibTeX
@article{Mu2026,
author = {Mu, Xiaoli and Meng, Wenjun and Zheng, Lingnan},
title = {Microenvironment-Driven Reprogramming in Colorectal Cancer Liver Metastasis: Metabolic, Phenotypic, and Immune Adaptation},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6206},
doi = {10.3390/ijms27146206}
}
EUVIMED